Select for export Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.comppsych.2025.152619 PubMed 40618640 Copy citation Copy BibTeX Comprehensive Psychiatry 2025-07-01 Luca Pellegrini, Naomi Fineberg, Sorcha O'Connor, Ana Maria Frota Lisbôa Pereira de Souza, Kate Godfrey, Sara Reed OpenAlex Published psilocybin DepressionOCDChronic Pain Clinical Trial More
Select for export Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-025-03035-8 PubMed 40281226 Copy citation Copy BibTeX Molecular Psychiatry 2025-04-25 Rebecca Harding, Neomi Singer, Matthew B. Wall, Talma Hendler, David Erritzøe, David Nutt OpenAlex Published psilocybin DepressionAnxietyBrain Imaging Other More
Select for export Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’ Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.78171 PubMed 39882198 Copy citation Copy BibTeX Cureus 2025-01-28 Sorcha O'Connor, Kate Godfrey, Sara Reed, Joseph Peill, Cyrus Rohani-Shukla, Mairead Healy OpenAlex Published psilocybin OCDChronic PainNeuroplasticity Other More
Select for export Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eclinm.2024.102799 PubMed 39764567 Copy citation Copy BibTeX EClinicalMedicine 2024-09-22 David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241237870 PubMed 38520045 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-03-21 David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11469-024-01253-9 Copy citation Copy BibTeX International Journal of Mental Health and Addiction 2024-03-06 Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Psychedelics and sexual functioning: a mixed-methods study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-023-49817-4 PubMed 38326446 Copy citation Copy BibTeX Scientific Reports 2024-02-06 Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph Peill, Leor Roseman, David Nutt OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-023-40856-5 PubMed 37608057 Copy citation Copy BibTeX Scientific Reports 2023-08-21 Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin J. Mallard, Daniel E. Roberts, David Erritzøe OpenAlex Published psilocybin Receptor PharmacologyMystical ExperienceSafety Other More
Select for export Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s0033291723001514 PubMed 37264814 Copy citation Copy BibTeX Psychological Medicine 2023-06-01 Brandon Weiss, Induni Ginige, Lu Shannon, Bruna Giribaldi, Ashleigh Murphy-Beiner, Roberta Murphy OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Body mass index (BMI) does not predict responses to psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131994 PubMed 36373934 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-11-13 Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T Europe PMC Published psilocybin Receptor PharmacologyWellbeingEmotional Processing Other More
Select for export Effects of psilocybin versus escitalopram on rumination and thought suppression in depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjo.2022.565 PubMed 36065128 Copy citation Copy BibTeX BJPsych Open 2022-09-05 Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Increased global integration in the brain after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41591-022-01744-z PubMed 35411074 Copy citation Copy BibTeX Nature Medicine 2022-04-10 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D Europe PMC Published psilocybin DepressionBrain ImagingReceptor Pharmacology Randomized Controlled Trial More
Select for export P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.335 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Hannah Douglass, Meg J. Spriggs, R.J. Park, Tim Read, Jennifer L. Danby, Frederico José Coelho de Magalhães OpenAlex Published psilocybin Eating DisordersReceptor Pharmacology Other More
Select for export Trial of Psilocybin versus Escitalopram for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1056/nejmoa2032994 PubMed 33852780 Copy citation Copy BibTeX New England Journal of Medicine 2021-03-31 Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R Europe PMC Published psilocybin DepressionReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881120959609 PubMed 33501857 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-10-07 Dea Siggaard Stenbæk, M. Madsen, Brice Ozenne, Sara Kristiansen, Daniel Burmester, David Erritzøe OpenAlex Published psilocybin Chronic PainReceptor PharmacologyConsciousness Other More
Select for export Psychedelic Psychiatry’s Brave New World No abstract availability was recorded for this entry. Details DOI 10.1016/j.cell.2020.03.020 PubMed 32243793 Copy citation Copy BibTeX Cell 2020-03-31 David Nutt, David Erritzøe, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAddictionReceptor Pharmacology Other More
Select for export P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.702 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels No abstract availability was recorded for this entry. Details DOI 10.1038/s41386-019-0324-9 PubMed 30685771 Copy citation Copy BibTeX Neuropsychopharmacology 2019-01-25 M. Madsen, Patrick M. Fisher, Daniel Burmester, Agnete Dyssegaard, Dea Siggaard Stenbæk, Sara Kristiansen OpenAlex Published psilocybinpsilocin PharmacologyReceptor Pharmacology Other More
Select for export Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2018.11.474 Copy citation Copy BibTeX European Neuropsychopharmacology 2018-12-31 M. Madsen, Daniel Burmester, Dea Siggaard Stenbæk, Søren Kristiansen, Agnete Dyssegaard, Szabolcs Lehel OpenAlex Published psilocybinpsilocin Receptor Pharmacology Other More
Select for export Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(16)30065-7 PubMed 27210031 Copy citation Copy BibTeX The Lancet Psychiatry 2016-05-16 Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
